Medicxi unveils €500m fund for asset-centric biotechs
Medicxi’s fund comes amid stronger calls from the European biopharma scene for fresh capital.
Investment
Sofinnova closes €650m healthcare fund for early-stage ventures
Biotechs brush off sector headwinds in venture financing rebound
MapLight’s $251m IPO sees schizophrenia drug developers on top
Bill Gates pledges $912m to combat infectious diseases amid US funding cuts
GSK plans $30bn investment for R&D in US
LB Pharmaceuticals tops 2025 biotech IPO list with $285m Nasdaq debut
UK pharma industry risks losing world-leading status as investment plummets
